Driven by its proprietary Enhanced Delivery Oligonucleotide (EDO) platform, PepGen is creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic diseases, with an initial focus on neuromuscular diseases.

Biotechnology

PepGen

PepGen's headquarters in Cambridge, MA, United States

This department provides governance and strategic direction at the executive level.

Executive Oversight

The Leadership Team at PepGen is responsible for strategic decision-making and overseeing the company's vision to develop innovative therapeutics targeting genetic diseases. Comprising experts from various disciplines including clinical science, research, toxicology, and manufacturing, this team drives the pipeline of disease-modifying therapies, ensuring alignment with the company's mission and effective project execution. Their collaborative efforts are essential for guiding PepGen through clinical advancements and maintaining regulatory compliance, ultimately aiming to improve patient outcomes in neuromuscular diseases.

Leadership Team

The Scientific Advisory team at PepGen provides expert guidance on research and development strategies for the company's therapeutic pipeline. Leveraging their specialized knowledge, they evaluate the efficacy and safety of candidates, ensuring they align with the goals of addressing the root cause of serious genetic and neuromuscular diseases.

Scientific Advisory

This department ensures that products and processes meet established quality standards and compliance regulations.

Quality Assurance

This department oversees analytical development, regulatory strategy, and clinical operations to ensure compliance and efficiency in product development.

Analytical and Regulatory Solutions

This department manages and oversees the planning, execution, and monitoring of clinical trials to ensure compliance and efficiency.

People (4)

Jobs (0)

Other teams

Leadership Team

Scientific Advisory

Quality Assurance

Analytical and Regulatory Solutions

Clinical Operations